EVG/COBI/FTC/TDF is well tolerated, according to randomized controlled trials results. Our aim was to evaluate the impact of this regimen on patients Experienced(E) or Naive(N) to combination Antiretroviral Therapy (cART) on Lipid profile, liver function and estimated glomerular filtration rate (eGFR) in a real life experience.
Metabolic, renal and liver events related to EVG/COBI/FTC/TDF use in SCOLTA project: a real life experience
PELLICANO', Giovanni Francesco;
2017-01-01
Abstract
EVG/COBI/FTC/TDF is well tolerated, according to randomized controlled trials results. Our aim was to evaluate the impact of this regimen on patients Experienced(E) or Naive(N) to combination Antiretroviral Therapy (cART) on Lipid profile, liver function and estimated glomerular filtration rate (eGFR) in a real life experience.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
